Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High density lipoprotein measurement
|
1440 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.800 | 1.000 | 7 | 2010 | 2019 | |||||
Triglycerides measurement
|
1418 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.800 | 1.000 | 7 | 2008 | 2019 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.800 | 1.000 | 6 | 2009 | 2019 | |||||
Serum total cholesterol measurement
|
1243 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.800 | 1.000 | 4 | 2010 | 2019 | |||||
Metabolic Syndrome X
|
591 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.800 | 1.000 | 1 | 2010 | 2010 | |||||
Serum LDL cholesterol measurement
|
555 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.700 | 1.000 | 3 | 2009 | 2013 | |||||
Serum albumin measurement
|
3282 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.700 | 1.000 | 2 | 2012 | 2013 | |||||
Serum HDL cholesterol measurement
|
679 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.700 | 1.000 | 2 | 2010 | 2013 | |||||
C-reactive protein measurement
|
624 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Coronary heart disease
|
1178 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
QT interval feature (observable entity)
|
226 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Hypertensive disease
|
1085 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.020 | 0.500 | 2 | 2017 | 2018 | |||||
Ischemic stroke
|
704 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||
Cardiovascular Diseases
|
711 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Coronary Artery Disease
|
1577 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of stomach
|
615 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.010 | 1 | 2018 | 2018 | ||||||
Stomach Carcinoma
|
652 | 0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 | 0.010 | 1 | 2018 | 2018 |